RE: If you believe in NFX25 Aug 2018 12:03
Well I got the cheapest stock I have bought in 7 months yesterday @ 2.50p, 40% below re-listing price. There are two risks at this stage, first, self-financing business: until we get a sustainable revenue stream from licensing royalties there is always the danger of dilutive placings. That may well be the reason the share has been trading around 2.50 again. Second there is the delivery risk, the business model sounds great in theory but we/the market need to see them bring one drug (presumably NPX001) right the way through to producing licensing revenue. After that we can be reassured about their ability to bring other drugs right the way through the process, obviously including NPX002.